Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.615
-0.045 (-2.71%)
Aug 28, 2026, 2:37 PM EDT - Market open
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $173.14 million as of August 28, 2026. Its market cap has decreased by -6.10% in one year.
Market Cap
173.14M
Enterprise Value
85.98M
1-Year Change
-6.10%
Ranking
Category
Stock Price
$1.62
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $173.14M, a decrease of -80.51%. That is a compound annual growth rate of -27.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 173.14M | 16.50% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 205.84M |
| Korro Bio | 202.04M |
| Conexeu Sciences | 202.03M |
| Satellos Bioscience | 199.27M |
| Humacyte | 194.79M |
| Cue Biopharma | 194.40M |
| Nkarta | 194.10M |
| Protalix BioTherapeutics | 193.37M |